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Background
« Nanomaterial means a natural, incidental or manufactured material 
containing particles….where…one or more external dimensions is in the size 
range 1 nm-100 nm. »
Source: European Commission Recommendation, 18 October 2011
Multi-walled carbon nanotubes (MWCNT) 
Developed for industrial purposes: mechanically strong, flexible, good 
electrical conductivity and thermal conductivity.
Potential applications include
composites, coatings, conductive 
plastics, sensors, batteries and fuel 
cells.
The Royal Society & The Royal Academy of Engineering, 2004
Source: http://www.turbosquid.com/
Background
Similarities with 
asbestos: 
fiber-like paradigm
SAFETY of MWCNTs?
•Takagi et al. 2008- mesothelioma
induction in p53+/- mice i.p. 3 mg MWCNTs
•Muller et al. 2009- no carcinogenicity in
rats exposed by i.p. to MWCNT
Estimated future global production of carbon nanotubes:
Source: The Royal Society & The Royal Academy of Engineering, 2004
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Singh et al. (2009) Biomaterials 30: 3891–3914
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To characterize the potential cyto- and genotoxic effects of 
two multi-walled carbon nanotubes (MWCNTs)  in a human 
type-II alveolar epithelial cell line (A549).
Objectives
NM402 NM403
Crystal Phase MWCNT MWCNT
Particle Size 100-10 000 nm long 100-10 000 nm long
Length (nm) 1 500 -
Diameter (nm) 11 -
Surface area 
[m2/g]
250 -
Impurities <10 wt % -
Use Structural composite and 
energy applications
Structural composite and 
energy applications
Source: JRC repository,  27 October 2011
Safety evaluation of manufactured nanomaterials by 
characterization of their potential genotoxic hazard
(NANOGENOTOX Joint Action (EU)
A549
human lung adenocarcinoma cell line
Methods
Clonogenic Assay In vitro Micronucleus assay
Fenech, M. Nature Protocols
2, 1084 - 1104 (2007)
Exposure of A549 cells to 
NM402 or NM403
Herzog et al.  (2007) Toxicology Letters,174, 49-60.
48h - exposure to NM8-days exposure
Colony : > 50 cells.
Surviving fraction:
No. of colonies formed after treatment   
No. of cells seeded x (plating efficiency/100)
Results- Clonogenic Assay
A concentration-effect relation was observed in 
A549 cells’ survival exposed to both NMs 
(exponencial model R2= 0,909 & 0,931). 
Results- Micronucleus Assay
Concentration-effect relation  for NM402  (quadratic 
model R2= 0.861). 
No concentration-effect relation for NM403. 
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Discussion
In the present study, while both NMs were cytotoxic for 
A549 cells, their ability to cause DNA damage was 
distinct.
NM402 caused a dose-dependent genotoxic effect.
NM403 was not genotoxic.
Discussion
Different toxicity of
each MWCNT
NM
NM
NM
Implications for nanomaterials
safety investigation
NM402 and NM403 are 
Closely related NMs… 
…present physicochemical 
differences that result in 
different genotoxic activities.
Research Team (INSA)
Ana Tavares
Susana Antunes
Ana Margarida Vicente
João Lavinha
Maria João Silva
Acknowledgments
The authors thank to 
all partners from NANOGENOTOX 
and all collaborators from INSA who 
have contributed to the present 
work.
This communication arises from the Joint Action NANOGENOTOX which has 
received funding from the European Union, in the framework of the Health 
Programme. It reflects only the authors' views and the Executive Agency for 
Health and Consumers is not liable for any use that may be made of the 
information contained therein (art. I.11.3 of the GA).
